Thomas E Morrison Selected Research

Lysine (L-Lysine)

10/2019

Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas E Morrison Research Topics

Disease

44	Infections 05/2024 - 01/2004
16	Virus Diseases (Viral Diseases) 03/2024 - 01/2008
12	Arthritis (Polyarthritis) 01/2020 - 01/2007
9	Alphavirus Infections 05/2024 - 10/2009
8	COVID-19 01/2023 - 01/2021
5	Inflammation (Inflammations) 10/2018 - 11/2008
4	Viremia 11/2021 - 10/2019
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 05/2007
3	Chikungunya Fever 03/2024 - 01/2016
2	Coronavirus Infections 05/2022 - 10/2018
2	Persistent Infection 01/2020 - 01/2014
2	Chronic Disease (Chronic Diseases) 01/2017 - 12/2013
2	Musculoskeletal Diseases (Musculoskeletal Disease) 11/2014 - 05/2013
2	Rheumatic Diseases (Rheumatism) 03/2014 - 05/2013
1	Hypoxia (Hypoxemia) 01/2023
1	Vascular Diseases (Vascular Disease) 04/2021
1	Thrombotic Microangiopathies 04/2021
1	Ross River Virus Infection 01/2021
1	Arthralgia (Joint Pain) 01/2020
1	Neoplasms (Cancer) 12/2019
1	Mycoses (Diseases, Fungus) 10/2018
1	RNA Virus Infections 01/2017
1	Vesicular Stomatitis 01/2016
1	Reoviridae Infections 01/2016
1	Parkinson Disease (Parkinson's Disease) 12/2015
1	West Nile Fever 12/2015
1	Necrosis 11/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Synovitis 12/2013
1	Tendinopathy (Tendonitis) 12/2013
1	Dengue (Dengue Fever) 10/2012

Drug/Important Bio-Agent (IBA)

18	Antiviral Agents (Antivirals)IBA 05/2024 - 01/2004
10	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2004
8	VaccinesIBA 05/2022 - 03/2014
7	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2012
7	Complement System Proteins (Complement)IBA 01/2023 - 05/2007
6	Viral RNAIBA 05/2024 - 12/2015
5	Neutralizing AntibodiesIBA 01/2023 - 01/2019
4	AntigensIBA 03/2024 - 10/2021
4	CytokinesIBA 04/2021 - 03/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 11/2008
3	Complement C3 (C3 Complement)IBA 01/2023 - 11/2008
3	EpitopesIBA 01/2021 - 01/2019
3	AntibodiesIBA 01/2021 - 01/2021
3	Interferon Type IIBA 01/2021 - 01/2007
3	Explosive Agents (Explosives)IBA 01/2020 - 11/2008
3	Arginine (L-Arginine)FDA Link 10/2019 - 01/2014
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2018 - 01/2012
3	Amino Acids FDA Link 11/2014 - 05/2013
2	I-antigenIBA 03/2024 - 11/2023
2	ChemokinesIBA 04/2021 - 10/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2019
2	Monoclonal AntibodiesIBA 12/2019 - 08/2014
2	Glycoproteins (Glycoprotein)IBA 10/2019 - 05/2013
2	Nucleic AcidsIBA 06/2017 - 01/2008
2	InterferonsIBA 10/2015 - 04/2014
2	Tyrosine (L-Tyrosine)FDA Link 05/2013 - 10/2009
2	Transcription Factors (Transcription Factor)IBA 08/2009 - 05/2004
1	4'-fluorouridineIBA 05/2024
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	Conditioned Culture MediaIBA 01/2023
1	complement C3a receptorIBA 01/2023
1	Complement Factor B (Factor B)IBA 01/2023
1	Complement C1q (C1q Complement)IBA 01/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2021
1	Immunoglobulin G (IgG)IBA 10/2021
1	Lipid NanoparticlesIBA 04/2021
1	Excipients (Suspending Agents)IBA 04/2021
1	Investigational DrugsIBA 01/2021
1	Broadly Neutralizing AntibodiesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	OvalbuminIBA 01/2020
1	Therapeutic UsesIBA 12/2019
1	Lysine (L-Lysine)FDA Link 10/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Peptide LibraryIBA 01/2019
1	LigandsIBA 01/2018
1	Polysaccharides (Glycans)IBA 01/2018
1	Capsid Proteins (Capsid Protein)IBA 06/2017
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2017
1	Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA 01/2016
1	Digoxin (Digitek)FDA LinkGeneric 01/2016
1	Cardiac GlycosidesIBA 01/2016
1	Ouabain (G Strophanthin)IBA 01/2016
1	alpha-SynucleinIBA 12/2015
1	GlycosaminoglycansIBA 11/2014
1	Complement Inactivating AgentsIBA 09/2014
1	LectinsIBA 09/2014
1	CollagenIBA 09/2014
1	Heparin (Liquaemin)FDA LinkGeneric 03/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014
1	EnzymesIBA 01/2014
1	Histidine (L-Histidine)FDA Link 05/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2012
1	ELAV-Like Protein 1IBA 10/2012

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2011
1	Immunomodulation 01/2020